Brainomix 360 e-CTA vs BrainScope TBI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Brainomix 360 e-CTA

by Brainomix Limited

BrainScope TBI

by BrainScope Company

AI Verdict

Brainomix 360 e-CTA focuses on acute stroke patients, utilizing CT angiography to detect large vessel occlusions and assess collaterals for treatment decisions like thrombectomy. BrainScope TBI, on the other hand, is an EEG-based device for rapid, point-of-care assessment of mild traumatic brain injury (mTBI), including concussions and brain bleeds, aiming to reduce unnecessary head CTs. While both deal with neurological conditions and leverage AI for diagnostic support, their primary focus, technology, and specific use cases are distinct.

Choose Brainomix 360 e-CTA if…

Choose Brainomix 360 e-CTA if your priority is rapid, AI-powered analysis of CT angiography scans for acute stroke patients. This tool excels at automating collateral assessment, detecting large vessel occlusions (LVOs), and providing objective data to support urgent treatment decisions like thrombectomy. It integrates seamlessly into existing radiology workflows, delivering results to PACS, mobile apps, or email within minutes.

View Brainomix 360 e-CTA →

Choose BrainScope TBI if…

Choose BrainScope TBI if you need a portable, non-invasive, and radiation-free solution for the rapid, objective assessment of mild traumatic brain injury (mTBI), including concussions and brain bleeds, at the point of care. This AI-powered EEG device can help reduce unnecessary head CT scans and provide objective diagnostic insights for both structural and functional brain injuries within minutes.

View BrainScope TBI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Brainomix 360 e-CTA	BrainScope TBI
Pricing	Contact vendor	Contact for pricing
Deployment	Cloud service (EU and US) and on-site server within the hospital network.	Portable point-of-care EEG assessment system (disposable headset + mobile interface) with a cloud-based EEG-to-biomarker analytics platform.
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BrainScope TBI

BrainScope TBI is a portable, point-of-care EEG assessment system with a disposable headset and mobile interface, designed for rapid assessment (under 20 minutes) at the patient's bedside. This makes it highly accessible and user-friendly in emergency or sports medicine settings. Brainomix 360 e-CTA, while offering mobile app access to results, relies on existing CT infrastructure and PACS integration, which involves a more complex workflow and less direct patient interaction at the point of care.

Clinical Value

BrainScope TBI

BrainScope TBI offers a non-invasive, radiation-free assessment for both structural (brain bleed) and functional (concussion) injuries, with studies showing a potential to reduce unnecessary head CTs by up to 60% and 99% sensitivity for detecting intracranial bleeds. Brainomix 360 e-CTA provides automated collateral assessment and LVO detection on CTA scans, which is valuable for acute stroke, but a recent real-world evaluation indicated a positive predictive value (PPV) of 0.5 for LVO detection, suggesting it should be used as an adjunct to expert interpretation.

Pricing & Value

Tie

Both tools require contacting the vendor for specific pricing, making direct comparison difficult. While BrainScope TBI highlights potential cost savings by reducing unnecessary CTs and patient length of stay, Brainomix 360 e-CTA also aims to improve workflow efficiency in stroke care, which can lead to cost benefits.

Enterprise Readiness

Brainomix 360 e-CTA

Brainomix 360 e-CTA is deployed as a cloud service or on-site server and integrates with PACS and other radiology systems, offering email and mobile app notifications, indicating a robust enterprise-level solution for stroke networks. BrainScope TBI, while portable and point-of-care, is primarily a device-based system with a cloud-based analytics platform, which may have different integration considerations within a larger enterprise IT infrastructure.

Innovation

BrainScope TBI

BrainScope TBI is an AI-powered EEG device that provides a non-invasive, radiation-free method for assessing both structural and functional brain injuries at the point of care, representing a significant innovation in mTBI diagnosis. It was also the first device in neurology cleared by the FDA under the AI/Machine Learning-Enabled Medical Device category. Brainomix 360 e-CTA offers advanced AI for automated CT angiography analysis in stroke, building upon existing imaging modalities, but BrainScope's approach to TBI assessment is a more novel diagnostic paradigm.

Support & Docs

Tie

Both companies provide support and documentation. Brainomix offers FAQs and user manuals on its website, along with contact information. BrainScope also provides user manuals and has extensive clinical validation studies published. Without more specific details on the breadth and accessibility of their support resources, it is difficult to definitively choose a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Brainomix 360 e-CTA	BrainScope TBI
Name	Brainomix 360 e-CTA	BrainScope TBI
Company	Brainomix Limited	BrainScope Company
Description	Brainomix 360 e-CTA is an AI-powered module within the Brainomix 360 Stroke platform that automates and standardizes the assessment of collaterals and detects large vessel occlusions on CT angiography scans for acute stroke patients.	BrainScope TBI is an FDA-cleared, AI-powered EEG device for rapid, objective assessment of mild traumatic brain injury (mTBI), including concussions and brain bleeds, designed to reduce unnecessary head CTs at the point of care.
Specialties	Emergency Medicine, Neurology, Radiology	Emergency Medicine, Neurology, Sports Medicine
Key Features	Automated collateral assessment on CTA scans, Computation of CTA Collateral Score (CTA-CS), Automatic Large Vessel Occlusion (LVO) detection, Indication of CTA acquisition phase for quality control, Multi-planar reconstructions (MPRs) with coronal, sagittal, and axial viewing, Integration within Brainomix 360 Stroke platform, DICOM results sent automatically to PACS or other radiology systems, Email result notifications	AI-powered EEG solutions, Non-invasive and radiation-free assessment, Portable and handheld point-of-care device, Rapid assessment (under 20 minutes), Detects both structural (brain bleed) and functional (concussion) injuries, Reduces unnecessary head CTs and radiation exposure, Provides objective diagnostic insights, Utilizes advanced digital signal processing and machine learning algorithms

Videos

Demos, reviews, and walkthroughs featuring Brainomix 360 e-CTA and BrainScope TBI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Brainomix 360 e-CTA is designed to fit into existing stroke pathways, automatically receiving routine NCCT scans from your hospital and delivering results to PACS, mobile app, email, or web UI within minutes. Brainomix 360 also integrates with existing enterprise directories like LDAP, Microsoft AD, and Single Sign-On. BrainScope TBI is a portable, point-of-care EEG system that easily integrates into emergency department workflows for mild head injuries and can be operated by non-nursing staff. BrainScope's EEG data can be downloaded to a PDF, and retrospective matched pairs of ED patients with mTBI have been derived from Allscripts EHR.

What are the accuracy and sensitivity of each tool for their respective indications?

Brainomix 360 e-CTA for large vessel occlusion (LVO) detection has shown a sensitivity of 0.86 and specificity of 0.88 in one study, with a negative predictive value of 0.99. Another real-world study reported a sensitivity of 0.78 and specificity of 0.93 for LVO detection, with a negative predictive value of 0.98. BrainScope TBI's Structural Injury Classifier (SIC) has demonstrated 99% sensitivity and 98% negative predictive value for acute traumatic intracranial bleeds. For concussion, its Brain Function Index (BFI) was shown to have high accuracy in identifying the likelihood of concussion within 72 hours of injury.

What is the learning curve for physicians and support staff, and what kind of support is available?

Brainomix 360 e-CTA is designed to provide automated assistance that improves scoring accuracy and reading efficiency for physicians across a range of experience. Brainomix offers user manuals and a contact support team. BrainScope TBI is described as simple to use and easily integrates into existing workflows, with assessments taking less than 20 minutes. Training from BrainScope was provided for successful implementation at one regional hospital. Patient and operator satisfaction with BrainScope TBI evaluation has been rated highly.

Beyond HIPAA, what security features are in place to protect patient data?

Brainomix 360 encrypts pseudonymized patient data in transit and at rest, and data retention is configurable by the user. Brainomix also adheres to GDPR, which implies robust data protection strategies. BrainScope TBI handles protected health information (PHI), and its FDA clearance for use in U.S. healthcare settings implies adherence to relevant security standards, though specific features beyond HIPAA are not explicitly detailed in the provided information.

What audit-trail features are available, and what are the considerations for multi-site rollouts?

Brainomix 360 Vantage provides real-time visibility on how the platform is performing across a network, allowing monitoring of outcomes, clinician engagement, and operational inefficiencies across every site and modality. This suggests robust audit and monitoring capabilities for multi-site deployments. Brainomix 360 Stroke has been deployed across four regional stroke networks in England, consisting of 26 hospitals, demonstrating its suitability for multi-site rollouts. The provided information for BrainScope TBI does not explicitly detail audit-trail features or specific multi-site rollout considerations, though its portability and ease of use could facilitate broader deployment.

In what clinical contexts would a physician choose one tool over the other?

A physician would choose Brainomix 360 e-CTA for acute stroke patients requiring rapid and automated assessment of collaterals and detection of large vessel occlusions on CT angiography scans. This tool is particularly useful in settings where streamlining patient triage for thrombectomy and standardizing stroke imaging interpretation is critical. BrainScope TBI would be chosen for rapid, objective assessment of mild traumatic brain injury (mTBI), including concussions and brain bleeds, at the point of care, especially to reduce unnecessary head CTs. It is beneficial in emergency departments, urgent care, concussion clinics, and sports medicine where a non-invasive, radiation-free assessment is desired.

More Comparisons

eCARTv5 Clinical Deterioration Suite (eCART) vs Google Med-PaLM 2

ChatGPT vs Google Med-PaLM 2

When choosing between ChatGPT and Google Med-PaLM 2, physicians should consider their primary use case and desired level of medical…

Brainomix 360 e-CTA vs Google Med-PaLM 2

DeepXray vs Google Med-PaLM 2

More matchups featuring Brainomix 360 e-CTA or BrainScope TBI

Backers

Who funded each tool's parent company.

Brainomix 360 e-CTA

Modi Ventures